Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Makes Final Decision On 'Inordinate' Out-Of-State Compounding
May 15 2020
•
By
Joanne S. Eglovitch
FDA's final offer of standard mou language on Interstate Compounding • Source: Shutterstock
More from Manufacturing
More from Compliance